Flow cytometer by BD Biosciences

BD LSRFortessa X-20 flow cytometer from BD Biosciences

The BD LSRFortessa X-20 flow cytometer from BD Biosciences (San Jose, CA) is a compact instrument that delivers multicolor analysis. The cytometer can be configured with up to five lasers to detect up to 20 parameters simultaneously, with a range of up to 34 available laser choices available as excitation sources. Each source is supported by new polygon detector arrays, and each polygon can support up to eight detectors. The analyzer is designed by the company’s special order program to enable tailored configuration to fit precise research and assay needs.

More Biophotonics Products

-----

PRESS RELEASE

New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research

BD LSRFortessa™ X-20 Cell Analyzer to Support Up to Five Lasers and 20 Parameters Simultaneously

San Jose, CA – BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD LSRFortessa™ X-20 Cell Analyzer, the latest in its line of high-performance research flow cytometers.

The BD LSRFortessa X-20 Cell Analyzer delivers high-performance multicolor analysis with the most compact footprint in its class at just 30” x 29” (76.2 X 73.7 cm) and a height of 30” (76.2 cm). Recognizing that space is a valuable commodity in today’s research environment, BD Biosciences designed the BD LSRFortessa X-20 Cell Analyzer to be compact without compromising the power needed.

Offering a new level of flexibility, the analyzer can be configured with up to five lasers to detect up to 20 parameters simultaneously. While popular laser choices include blue, red, violet, yellow-green and UV, a wide range of up to 34 available laser choices are available as excitation sources. Each excitation source is supported by new polygon detector arrays, and each polygon can support up to eight detectors for maximum flexibility in optical configuration.

The BD LSRFortessa X-20 Cell Analyzer is designed by BD’s special order program that enables customers to configure BD flow cytometers and cell sorters to fit precise research and assay needs.This program is tailored to meet the needs of researchers at the leading edge of biomedical discovery. The platform is also supported by a full range of BD Biosciences reagents.

“The new BD LSRFortessa X-20 Cell Analyzer will enable researchers to conduct complex experiments with the additional parameters and increased sensitivity they need,” said Alberto Mas, President, BD Biosciences. “Uncovering dim staining and rare cell populations is extremely valuable to complex multicolor assays, which are tools for advanced disease or drug development research.”

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

POST A COMMENT

Related Articles

Five nonablative fractional laser treatments yielded significant improvement (right) in the number and severity of LMDF skin lesions

Nonablative fractional laser improves inflammatory skin disorder appearance

In a new study, a team of researchers has demonstrated the use of a 1565 nm nonablative fractional laser to treat Lupus miliaris disseminates faciei (LMDF), an inflammatory skin disorder.

AMD Lasers' Picasso dental laser wins award for fifth year

Dental laser maker AMD Lasers has been honored as the "number one" choice of dentists for soft-tissue dental lasers, as the company's Picasso dental laser has won Dentaltown Magazine's To...
TSRI associate professor Ashok Deniz (left) and research associate Priya Bangerjee are among the authors of the new Nature Communications paper on an infrared light-activated microfluidic device

Infrared light-activated microfluidic device probes how molecules fold

A team of researchers has developed a microfluidic device that, when activated by infrared (IR) light from a laser, can observe how proteins and other biomolecules form and lose their natural folde...
Global medical aesthetic devices market to reach $6.2B by 2019, says new report

Global medical aesthetic devices market to reach $6.2B by 2019, says new report

In a new report, BCC Research has revealed that the growing expansion of the middle classes in developing economies, shifts in cultural outlooks for developed economies, and regulatory actions in t...
BLOGS

Single-molecule tracking promises discoveries, cures

New ways of imaging individual proteins and lipids will ultimately change science and medicine.

Growth in lasers for medicine

At the Lasers and Photonics Marketplace Seminar during SPIE Photonics West 2015, analyst Allen No...

Also at BiOS 2015

Although the BiOS Expo closes on Sunday, February 8, 2015, the conferences of the Biomedical Opti...

Most Popular Articles


CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2014. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS